LAI Additive Manufacturing team has selected Arcam EBM technology
May 12, 2016
MÖLNDAL, Sweden--(BUSINESS WIRE)--Regulatory News:
Arcam (STO:ARCM), listed on NASDAQ Stockholm and leading supplier of Additive Manufacturing solutions, has agreed on a supply agreement for Arcam Q20plus systems to LAI International in the US. LAI has selected Arcam Q20plus technology for their Additive Manufacturing activities in the aerospace industry.
LAI International supplies advanced titanium and other specialty metals products and services to the commercial aerospace, defense, oil & gas and medical device markets. LAI, who purchased their first Arcam Q20 system in 2015, recently placed an order for a second system and are now quickly moving beyond aerospace proof of concept and into production. LAI will be one of the first customers for the recently released Arcam Q20plus.
“We at LAI International are pleased to have selected the Arcam Q20plus system to support our growing aerospace applications for 3D printing and additive manufacturing. The machines build size, speed and material performance makes it a good fit for LAI commercial products. Arcam has proven to be a critical strategic partner to LAI and we look forward to a long term relationship”, says Patrick J. (PJ) Gruetzmacher, President of LAI International.
"Our activities in the aerospace industry are growing quickly and we are very happy that LAI International, an important client and tier one supplier to the aerospace industry, are now growing the use of our EBM technology", says Magnus René, CEO of Arcam.
Arcam Group provides cost-efficient Additive Manufacturing solutions for production of metal components. Arcam’s Electron Beam Melting (EBM®) technology offers design freedom combined with excellent material properties and high productivity. Arcam is, through its solution orientation and comprehensive product offering, an innovative partner for advanced manufacturing, primarily for the aerospace and medical industries. Arcam offers EBM systems through Arcam AB in Sweden, powder metals through AP&C in Canada and implant contract manufacturing through DiSanto in the U.S.The company is listed on Nasdaq Stockholm and the Head Office is located in Mölndal, Sweden.